amikacin has been researched along with cefoperazone in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (26.19) | 18.7374 |
1990's | 11 (26.19) | 18.2507 |
2000's | 8 (19.05) | 29.6817 |
2010's | 11 (26.19) | 24.3611 |
2020's | 1 (2.38) | 2.80 |
Authors | Studies |
---|---|
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bai, N; Cai, Y; Li, R; Liang, B; Liu, Y; Wang, R | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ciebieda, I; Denys, A; Ferszt, T; Korczak, E | 1 |
Anderson, PH; Barry, AL; Fuchs, PC; Shilling, S; Stickel, S | 1 |
Kobayashi, J; Kouda, M; Kumagai, I; Matsuzaki, H; Sugai, R | 1 |
Bale, M; Howard, W; Koontz, F; Pfaller, M; Preston, T | 1 |
Belobraydic, KA; Flournoy, DJ; Qadri, SM | 1 |
Bulliard, G; Husson, M; Van der Auwera, P | 1 |
Hernández, NI; Nevárez, M; Ramírez-Ronda, CH; Rodríguez, JR | 1 |
Klastersky, J; Lagast, H; Van Laethem, Y | 1 |
Catarinelli, L; Celi, F; Crapa, G; De Rosa, F; Frongillo, RF; Luzzi, L; Moretti, MV; Palumbo, M; Rossi, A; Sciannameo, F | 1 |
Meyer, RD; Pasiecznik, K | 1 |
Accornero, L; Bacigalupo, A; Carella, AM; Congiu, AM; Costa, G; Occhini, D; Santini, G; Sbaffi, A; Sciutto, C; Van Lint, MT | 1 |
Husson, M; Klastersky, J; Van Laethem, Y | 1 |
Chang, ST; Chung, ES; Whang, CW | 1 |
Klastersky, J; Lagast, H; Meunier, F; Piccart, M; Van Laethem, Y; Weerts, D | 1 |
Cavallo, JD; Chevalier, B; Meyran, M | 1 |
Hirose, S; Inoue, T; Ito, K; Mano, K; Mita, S; Morita, Y; Sukoh, M; Takahashi, T; Togano, Y; Yamanaka, K | 1 |
Kawada, E; Maehara, T; Matsushima, T; Morita, K; Murayama, K; Okamoto, K; Sadakata, H; Sawamura, M; Tamura, J; Tamura, K | 1 |
Fukuda, M; Hirashima, K | 1 |
Hirakawa, K; Horiike, S; Kuzuyama, Y; Misawa, S; Nakai, H; Nishida, K; Seriu, T; Takashima, T; Tanaka, S; Tsuda, S | 1 |
Martínek, J; Melenovsky, V; Morávek, J; Spicák, J; Závada, F | 1 |
Mayer, I; Nagy, E | 1 |
Başkan, S; Ozyilkan, O; Yalçintaş, U | 1 |
Bessho, M; Endo, K; Fukuda, M; Hirasima, K; Ito, K; Kawai, N; Tominaga, K | 1 |
Perederko, LV; Polikarpova, SV; Postnikov, SS; Semykin, SIu | 1 |
Hashikita, G; Kawakami, S; Kobayashi, S; Maesaki, S; Nagasawa, M; Okabe, T; Sasaki, K; Shibuya, S; Suzuki, N; Takayama, S; Uchida, T; Watanabe, M; Yamaguchi, T | 1 |
Alp, E; Aygen, B; Metan, G; Sumerkan, B | 1 |
Duttagupta, S; Kochhar, P; Sarkar, S; Suvarna, V | 1 |
Chandra, A; Desai, C; Dhar, P; Dharap, S; Goel, A; Gupta, R; Hardikar, JV; Kapoor, VK; Kochhar, P; Mathur, AK; Modi, P; Narwaria, M; Ramesh, H; Ramesh, MK; Sastry, RA; Schou, M; Shah, S; Somasundaram, S; Sreevathsa, MR; Sudheer, OV; Varshney, S; Virk, S | 1 |
Blahut, L; Hricová, K; Kolár, M; Neiser, J; Urbánek, K; Uvízl, R; Vojtová, V | 1 |
Celebi, S; Demirkaya, M; Hacımustafaoglu, M; Sevinir, B | 1 |
Hong, J; Hu, J; Ke, F | 1 |
Gao, L; Li, Y; Lyu, Y | 1 |
Ali, I; Shabbir, M | 1 |
Cai, Y; Wang, J; Wang, R; Yang, D | 1 |
Cyriac, SL; Dubashi, B; Harish, BH; Jadhav, N; Jaffa, E; Kayal, S; Matta, KK; Pattnaik, J; Pillai, US; Ponraj, M; Prakash, B; Ranjith, K; Singh, J | 1 |
Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A | 1 |
Cao, Y; Liu, C; Ren, H; Shang, Z; Wang, R; Xie, L; Yang, Y; Zhang, J | 1 |
1 review(s) available for amikacin and cefoperazone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 trial(s) available for amikacin and cefoperazone
Article | Year |
---|---|
Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Pseudomonas Infections; Sepsis; Staphylococcal Infections | 1984 |
[Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bronchitis; Cefoperazone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Sulbactam; Tobramycin | 1994 |
[Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Cefoperazone; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Sulbactam | 1993 |
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Cefoperazone; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam | 1999 |
[Efficacy and safety of cefoperazone/sulbactam in the treatment of children with mucoviscidosis during exacerbation of the bronchopulmonary process].
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefoperazone; Child; Child, Preschool; Cystic Fibrosis; Drug Therapy, Combination; Female; Humans; Male; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Treatment Outcome | 2003 |
Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting.
Topics: Abdomen; Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefoperazone; Ceftazidime; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; Female; Humans; India; Male; Metronidazole; Middle Aged; Sulbactam; Treatment Outcome | 2008 |
Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Child; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Male; Metronidazole; Middle Aged; Peritonitis; Sulbactam; Treatment Failure; Treatment Outcome | 2008 |
Randomized comparison of piperacillin-tazobactam plus amikacin versus cefoperazone-sulbactam plus amikacin for management of febrile neutropenia in children with lymphoma and solid tumors.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Sulbactam; Tazobactam | 2013 |
Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Cefepime; Cefoperazone; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Sulbactam; Survival Analysis; Withholding Treatment; Young Adult | 2018 |
32 other study(ies) available for amikacin and cefoperazone
Article | Year |
---|---|
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Colistin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mutation | 2010 |
[Effect of TFX (Polfa) on the course of experimental bacterial infections in mice treated with ciprofloxacin, amikacin and cefoperazone].
Topics: Amikacin; Animals; Cefoperazone; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Escherichia coli Infections; Female; Male; Mice; Mice, Inbred BALB C; Staphylococcal Infections; Staphylococcus aureus; Thymus Extracts | 1992 |
In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Cefoperazone; Drug Interactions; Drug Therapy, Combination; Gentamicins; Immunoenzyme Techniques; Netilmicin; Piperacillin; Sulbactam; Tobramycin | 1991 |
[Combined effect of sulbactam/cefoperazone and other antibiotics against clinical isolates of multi-resistant strains. II. In vitro combined effects of sulbactam/cefoperazone with imipenem/cilastatin, cefuzonam, flomoxef, amikacin or tobramycin].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Cefoperazone; Ceftizoxime; Cephalosporins; Cilastatin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Sulbactam; Tobramycin | 1991 |
In vitro inhibitory and bactericidal activity of cefpiramide and seven antipseudomonal agents against Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefsulodin; Ceftazidime; Cephalosporins; Drug Combinations; Drug Synergism; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Time Factors; Tobramycin | 1986 |
Comparison of antimicrobial susceptibilities of Pseudomonas aeruginosa isolates, with and without plaques, from two hospitals.
Topics: Amikacin; Carbenicillin; Cefoperazone; Gentamicins; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Ticarcillin; Tobramycin | 1986 |
Study of in vitro selected resistance of Pseudomonas aeruginosa to cefoperazone, ceftazidime, azthreonam and imipenem.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Cefoperazone; Ceftazidime; Drug Resistance, Microbial; Imipenem; Phenotype; Pseudomonas aeruginosa; Thienamycins | 1986 |
Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
Topics: Amikacin; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Drug Synergism; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa | 1985 |
Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae.
Topics: Amikacin; Anti-Bacterial Agents; Blood Bactericidal Activity; Cefoperazone; Ceftazidime; Cephalosporins; Drug Synergism; Humans; Kanamycin; Klebsiella pneumoniae; Pseudomonas aeruginosa | 1983 |
[Our experience with sodium cefoperazone].
Topics: Amikacin; Cefoperazone; Drug Synergism; Escherichia coli Infections; Humans; Meningitis; Pseudomonas Infections; Urinary Tract Infections | 1984 |
In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Synergism; Imipenem; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins | 1983 |
Cefoperazone versus cefotaxime, plus amikacin or sisomicin, in fever and infection in hematologic granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anemia, Aplastic; Cefoperazone; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Immunosuppression Therapy; Infections; Kanamycin; Leukemia; Male; Middle Aged; Random Allocation; Sisomicin | 1984 |
Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Bacteria; Bacteriological Techniques; Cefoperazone; Drug Therapy, Combination; Escherichia coli; Humans; Kanamycin; Klebsiella pneumoniae; Pseudomonas aeruginosa; Serratia marcescens; Time Factors | 1984 |
Comparative study of cefoperazone and amikacin.
Topics: Amikacin; Bacteria; Cefoperazone; Humans; Kanamycin; Microbial Sensitivity Tests; Surgical Wound Infection | 1984 |
[Bactericidal activity of 6 antibiotics and 3 combinations against 6 strains of Salmonella isolated from blood].
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftriaxone; Chloramphenicol; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Salmonella | 1995 |
[Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Cefoperazone; Drug Evaluation; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Male; Middle Aged; Sulbactam | 1993 |
[A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Cefoperazone; Drug Combinations; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Immunocompromised Host; Leukocyte Count; Male; Middle Aged; Neutrophils; Sulbactam | 1993 |
Penetration of antibiotics into the pancreas in rats: an effect of acute necrotizing pancreatitis.
Topics: Amikacin; Amoxicillin; Animals; Anti-Bacterial Agents; Cefoperazone; Clavulanic Acid; Female; Ofloxacin; Pancreas; Pancreatic Juice; Pancreatitis, Acute Necrotizing; Piperacillin; Rats; Rats, Wistar; Taurocholic Acid; Tissue Distribution | 1999 |
Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Pseudomonas | 1999 |
[Clinical analysis of neutropenic fever associated with hematological disorders].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Infective Agents, Urinary; Cefoperazone; Drug Combinations; Drug Therapy, Combination; Female; Fever; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Serum Albumin; Sulbactam | 2001 |
[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Oxazines; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Thienamycins | 2006 |
Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis.
Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Thienamycins; Turkey | 2007 |
Antibiotic utilization and Pseudomonas aeruginosa resistance in intensive care units.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Ciprofloxacin; Czech Republic; Drug Resistance, Multiple, Bacterial; Gentamicins; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam | 2011 |
Experimental Induction of Bacterial Resistance to the Antimicrobial Peptide Tachyplesin I and Investigation of the Resistance Mechanisms.
Topics: Aeromonas hydrophila; Amikacin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cefoperazone; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Mutation; Peptides, Cyclic; Proteolysis; Pseudomonas aeruginosa; Selection, Genetic; Ultraviolet Rays | 2016 |
Trends in Drug Resistance of
Topics: Acinetobacter baumannii; Amikacin; Anti-Infective Agents; Cefepime; Cefoperazone; Ceftazidime; Cephalosporins; China; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2017 |
Antibiotics susceptibility patterns of uropathogenic E. coli with special reference to fluoroquinolones in different age and gender groups.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Cefoperazone; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Imipenem; Infant; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sulbactam; Tazobactam; Urinary Tract Infections; Young Adult | 2017 |
Amikacin and cefoperazone/sulbactam alone or in combination against carbapenem-resistant Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefoperazone; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Luminescent Measurements; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 2018 |
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2018 |
Characteristics of and antibiotic resistance in urinary tract pathogens isolated from patients with upper urinary tract stones.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Cefoperazone; Drug Resistance, Bacterial; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Male; Microbial Sensitivity Tests; Piperacillin; Sulbactam; Tazobactam; Urinary Calculi; Urinary Tract; Urinary Tract Infections | 2023 |